Semaglutide for weight loss in overweight adults
Part of Hormones & metabolism clinical trials.
This study tests if the medication semaglutide helps adults with overweight or obesity lose weight safely. It includes people with or without type 2 diabetes, and aims to see how well the drug works in a Bangladeshi population.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is 30 or higher, or between 25 and 29.9 with a weight-related health issue like high blood pressure, high cholesterol, sleep apnea, or heart disease.
- If you have type 2 diabetes, it must have been diagnosed at least 6 months ago and your HbA1c should be 12% or lower.
- You have not lost more than 5 kg (about 11 pounds) in the last 30 days without trying, and you are not currently on prescription weight-loss medication.
- You do not have a history of pancreatitis, eating disorders, thyroid cancer, or recent major depression or suicidal thoughts.
- You are not pregnant or breastfeeding, and your kidney function is generally adequate (eGFR above a certain level).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This trial tests if semaglutide (a weekly injection) helps people who lost less weight than expected after gastric bypass or sleeve surgery. It's for patients who had a high BMI before surgery and are in a special support program.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.